Dr robert j lefkowitz nobel
Home / Scientists & Inventors / Dr robert j lefkowitz nobel
In GPCRs, this process begins when an agonist binds to the receptor, activating it. His research uncovered the unique seven-pass structure of GPCRs and their activation and desensitization mechanisms, which are crucial for cellular communication. Desensitization is a mechanism where a receptor becomes less responsive to a stimulus over time, which is crucial for maintaining cellular homeostasis [1].
When necessary, the brain can make the body react to outside stimuli, but how are these messages conveyed? Robert Lefkowitz’s Nobel Prize-winning research focuses on GPCRs, which are integral to numerous physiological processes. Personal interview. Dr. Lefkowitz’s journey into the realm of receptors began with his fascination with the beta-adrenergic receptor, a critical receptor through which adrenaline operates [1].
Receptors are molecules located on the surfaces of cells that allow other molecules to latch onto them, either to relay a signal or to facilitate the entry of substances into the cell [2].
His discoveries have paved the way for new treatments and provided a framework for studying other receptor families.
Conducted by Grace Go and Yeongseo Son. 27 September 2023.
[2] Miller, Eric J. “Physiology, Cellular Receptor.” StatPearls [Internet]., September 14, 2022. This discovery has greatly helped the development of medications.
Robert Joseph Lefkowitz was born in the Bronx, New York, in April 1943. https://www.ncbi.nlm.nih.gov/books/NBK554403 .
[3] Rajagopal, Sudarshan, and Sudha K Shenoy.
His research into the beta-adrenergic receptors, a subset of GPCRs activated by adrenaline, provided deep insights into how these receptors function and how they can be manipulated for therapeutic purposes.
Dr. He has served as an Investigator of the Howard Hughes Medical Institute since 1976 and was an Established Investigator of the American Heart Association from 1973-6.
.
.
Thanks to his Bronx scientific background he received his BA in chemistry in 1962, at the age of 19, and progressed to the Columbia University College of Physicians and Surgeons in New York, gaining his MD degree in 1966.After staying on for an internship and residency at the college, Lefkowitz moved to the National Institutes of Health (NIH) in Bethesda, Maryland, as a clinical and research associate.
The introduction of beta blockers in clinical practice in 1968 was a significant advancement in medicine, as these drugs work by blocking beta-adrenergic receptors to manage heart conditions [1].
Techniques for Studying Beta Adrenergic Receptors
To study these receptors, Dr. Lefkowitz developed several innovative techniques: the radioligand binding assay, affinity chromatography, and gene cloning.
These interactions are fundamental to numerous physiological processes, making receptors key targets for many therapeutic drugs. Robert attended the Bronx High School of Science (which has produced eight Nobel Laureates) and in 1959 went on to Columbia College, where he first became interested in biochemistry. Lefkowitz was promoted to Professor in 1977 and James B Duke Professor of medicine in 1982, also holding professorships in chemistry and biochemistry.
GPCRs are a large family of receptors, characterized by their unique structure: a single polypeptide chain that weaves through the plasma membrane seven times [1]. Lefkowitz’s research demonstrated that this desensitization mechanism is vital for preventing the overstimulation of cells and ensuring that they return to their unstimulated state after being activated.
Beta-arrestin then binds to the phosphorylated receptor, leading to desensitization by preventing further signaling through the receptor [3].
Dr. The team soon discovered that the receptor was similar to one in the eye that senses light and realised that there is a whole family of these G-protein–coupled receptors, which function similarly for light, flavour, odour, adrenalin, histamine, dopamine, serotonin and others.
Dr. Lefkowitz advocates for embracing failure and curiosity, underscoring that perseverance is key to overcoming challenges and achieving success in scientific discovery.
Understanding Receptors
The work of Dr. Robert Lefkowitz has significantly advanced our understanding of how GPCRs function, impacting the development of numerous FDA-approved drugs.
By attaching a radioactive isotopes to various hormones he managed to trace their progress through the body to highlight several receptors, including the ß-adrenergic receptor for adrenalin.
His team extracted the receptor from cell membranes and gained understanding of how it works, but it was not until the 1980s that further advances in gene cloning enabled new recruit Brian Kobilka, with whom Lefkowitz shares the award, to isolate the gene coding for the ß-adrenergic receptor from the human genome.